US Joins Patent Pool To Promote Generic HIV Drugs

Law360, New York (September 30, 2010, 12:17 PM EDT) -- The National Institutes of Health announced Thursday it would join an international patent pool to help increase the availability of drugs to treat HIV and AIDS in developing countries, becoming the first patent holder to do so.

The so-called Medicines Patent Pool is a new initiative designed to streamline patent licensing for the production of generic versions of patented HIV treatments and lower prices for the medications in developing countries by encouraging competition.

On Thursday, the NIH agreed to share its intellectual property related to a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.